Audio Journal of Oncology – June 7th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6

Audio Journal of Oncology – June 7th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6

0:00
6 June 2006

Robert Ozols Lawrence Wickerham Patricia Ganz Jorma Paavonen Noah Kauff Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer pre

Robert Ozols


Robert Ozols

Lawrence Wickerham


Lawrence Wickerham

Patricia Ganz


Patricia Ganz

Jorma Paavonen


Jorma Paavonen

Noah Kauff


Noah Kauff

Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer prevention.

– Raloxifene is as good as tamoxifen at preventing breast cancer in high-risk women. Lawrence Wickerham of the National Surgical Adjuvant Breast and Bowel Project in Pittsburgh presented the clinical data from the STAR trial, while Patricia Ganz of UCLA had information on quality of life (Abstracts 5 and 561)
– The human papillomavirus vaccine (HPV) doesn’t just protect against cervical cancer – it may protect against vaginal and vulvar cancers as well. That’s according to findings from the FUTURE II study, presented by Jorma Paavonen of the University of Helsinki (Abstract 5011)
Noah Kauff, of the Memorial Sloan-Kettering Cancer Center in New York, has data confirming that women with mutations in the genes for BRCA1 and 2 can reduce their risk of breast and ovarian cancer if they have their ovaries and fallopian tubes removed (Abstract 1003)


[audio:https://www.audiomedica.com/podcasting/asco/06.06.07_ASCO_podcast.mp3]

Related Episodes

Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls

Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls

The cancer prevention benefit of vaccination against the human papilloma virus cancer prevent are slowly accruing thanks to European, American and other population-based studies.  I’m Peter Goodwin wi

1 October 2025
6:07
More
Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025

Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025

Luis G Paz-Ares MD PhD discdusses the addition of lurbinectedin as maintenance therapy for extensive stage small cell lung cancer (SCLC)

30 June 2025
11:51
More
Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab Added to Standard Chemotherapy

Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab Added to Standard Chemotherapy

An interview with: Frank A Sinicrope, MD, Medical Oncologist, Mayo Clinic, Rochester, Minnesota. CHICAGO —Big gains in survival have been reported among patients with stage three, node-positive colon

10 June 2025
7:24
More